← Evidence map

ArticleTherapeutics and clinical risk management2015

Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study.

Hiromichi Yamane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2015
2016
2017
2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26124663